期刊文献+

正电子成像和正电子成像/计算机成像在妇科肿瘤中的应用 被引量:7

The Application of PET and PET/CT in Gynecologic Cancer
下载PDF
导出
摘要 与影像学方法比较,利用正电子成像和正电子成像/计算机成像,能更准确地检测到妇科肿瘤。2-[18F]氟-2-脱氧葡萄糖正电子成像用于鉴别淋巴结的良恶性、测量治疗后残留灶或复发灶的大小。在放疗计划制订中,正电子成像/计算机成像提供了更多的诊断信息,指导组织活检。本文就正电子成像和正电子成像/计算机成像在妇科肿瘤诊断、分期、复发、评价治疗效果和预后判断等方面的应用做一综述。 The advent of positron emission tomography (PET) and PET/computed tomography (CT) now enables us to detect metabolically active gynecologic cancers with greater accuracy. Fuorine-18 fluorodeox- yglucese PET has been used in differentiation of malignant from benign lymph nodes and residual or recurrent cancers from post-treatment changes. PET/CT supply additional information for the diagnosis and tissue biopsy as well as radiotherapy planning. This paper reviewed the principle and clinical utility of PET and PET/CT in the diagnosis, staging, recurrence, therapeutic response as well as prognosis of gynecologic cancers.
出处 《医学综述》 2008年第3期344-346,共3页 Medical Recapitulate
关键词 妇科肿瘤 正电子成像 正电子成像/计算机成像 Gynecologic cancer Positron emission tomography Positron emission tomography/computed tomography
  • 相关文献

参考文献23

  • 1Wahl RL, Quint LE, Cieslak RD, et al. Anatometabolic tumor imaging: fusion of FDG PET woth CT or MRI to localize foci of increased activity [J] .J Nucl Med,1993,34(7) :1190-1197.
  • 2Beyer T, Townsend DW, Brim T, et al.A combined PET/CT scanner for clinical oncology [J] .J Nucl Med,2000,41(8) : 1369-1379.
  • 3Chou CY. Color Doppler ultrasonography and serum CA125 in the differentiation of benign and malignant ovarian tumors[J] .J Clin Ultrasound, 1994,22(8) :491-496.
  • 4Grab D, Flock F, Stohr I, etal. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and position emission tomography [J]. Gynecol Oncol,2000,77(3) :454-459.
  • 5Hubner KF,McDonald TW, Niethammer JG, etal. Assessment og primary and metastatic ovarian cancer by positron emission tomography using 2-[ ^18 F] deoxyglucose[ J]. Gynecol Oncol, 1993,51 (2) : 197-204.
  • 6Zimny M, Schroder W, Wolters S, etal. ^18 F-fluoro-deoxyglucose PET in ovarian carcinoma: methodology and preliminary results [ J ]. Nuldearmedizin, 1997,36(7) :228-233.
  • 7Schroder W, Zinmy M, Rudlowski C, et al. The role of 18F-fluoro-deoxyglucose positron emission tomography in diagnosis of ovarian cancer [J]. Int J Gynecol Cancer, 1999,9(2) : 117-122.
  • 8Omura GA,Bradhy MF,Homesley HD, et al. long-term follow-up and prognostic factor analysis in advancer ovarian carcinoma: the Gynecologic Oncologic Group experience [J] .J Clin Oncol, 1991,9(7) : 1138- 1150.
  • 9Holschneider CH, Munro MG, Williams CM, et al. FDG-PET in ovarian cancer: use of the standardized uptake value (SUV) to differentiate physiological bowel activity from intraperitoneal metastatic tumor[ J] .J Nucl Med,2002,43 ( 1 ) :29.
  • 10Ozols RF. Chemotherapy of ovarian cancer. In: DeVita VT, HeUman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology [ M ] Updates. Philaddphia: JB Lippincott, 1988.1 - 12.

同被引文献44

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部